CART — Maplebear Inc. - Common Stock
Session close: $60.88. Regular-session share volume: 29,633,774. Change from previous close: +7.87%.
Key developments
Instacart has halted differential pricing experiments amid heightened regulatory scrutiny, according to session-day reporting. Several states have introduced or passed restrictions on personalized and data-driven pricing, while consumer advocates are pressing retailers and platforms over personal-data use and pricing transparency. The report does not quantify the business impact of stopping the experiments.
Instacart Halts Differential Pricing Experiments Amid Regulatory Scrutiny
Earlier reporting said Maplebear agreed to a settlement with U.S. authorities over past PERM hiring practices, adding compliance obligations, policy changes and monitoring.
Instacart Stock What Health Benefits Deal And $5 Million Settlement Mean
The earlier report also said True Rx Health Strategists selected Instacart to power an employer-funded healthy food benefit through Instacart Health Fresh Funds. The planned program places Instacart within pharmacy benefit design and links employer spending to clinically supervised food choices, though the supplied evidence does not establish its financial contribution.
Instacart Stock What Health Benefits Deal And $5 Million Settlement Mean
News sources
Company news Maplebear shares are trading lower after Form 4 filings showed its executives sold company stock. · Company news Citizens Maintains Market Outperform on Maplebear, Raises Price Target to $65